Shelter Pharma Ltd Secures International Order from Al-Saqr Agro Worth USD 27,664
Shelter Pharma Ltd has secured a significant international purchase order from Al-Saqr Agro for its Agricultural and Veterinary Entries. This contract is noted as a key milestone reflecting the company's expanding acceptance in global markets.The international order details indicate that Shelter Pharma Ltd will supply various Veterinary Feed Supplements products to Al-Saqr Agro. The total commercial consideration for this order amounts to USD 27,664.
The specific products included in the purchase orders are: Multina Liquid Unit (1L), Unit (3L), and Super Vitamas Unit (20kg). Payment terms associated with the order stipulate a 100% advance upon placement of the order, with pricing set at CNF. The agreed delivery time is two months from the date of payment.
The transaction was conducted entirely at arm's length, with no interest held by the promoter or the promoter group in Al-Saqr Agro. This development is expected to contribute positively to Shelter Pharma Ltd’s revenue and overall business expansion as it strengthens its global presence.
Details of the purchase order are summarized below:
| Product Name | Key Specifications | Commercial Details |
|---|---|---|
| Multina Liquid Unit | 1L | 1020 units at USD 3,264 each |
| Unit (Liquid Feed Supplement) | 3L | 1000 units at USD 9,000 each |
| Super Vitamas Unit | 20kg | 700 units at USD 15,400 each |
The order is scheduled to be executed within the mutually agreed timelines as per the purchase order and shipment schedule.
Stock Price Movement
As of 12:51 PM, Shelter Pharma Ltd shares are ticking up at ₹26.78, climbing 4.00% in trading today. The stock has been active within its intraday range, moving between a low of ₹25.75 and an high of ₹26.78.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.